Novel Therapeutics Targeting the Host-Pathogen Interaction 2.0

Dear Colleagues,

This Special Issue is a continuation of our 2022 Special Issue "Novel Therapeutics Targeting the Host-Pathogen Interaction".

Currently, there is an urgent need for new strategies to combat human diseases caused by intracellular pathogens, including viruses, intracellular bacteria, and protozoa. An attractive solution to fulfill this demand is to repurpose already approved drugs that target host functions required for the lifecycle of intracellular pathogens. Off-label use of approved drugs requires significantly less capital and time and diminishes the clinical risks because such drugs are already rigorously tested for their primary indication. To effectively meet the clinical needs posed by emerging intracellular pathogens, host-targeted broad-spectrum therapies may find utility. For this reason, the knowledge of host-pathogen interactions is vital for our understanding of infectious diseases, as well as their spread, development, treatment, and prevention. Therefore, a comprehensive understanding of host-pathogen interaction can provide important new insights into the identification of novel targets for both host effectors and microbial factors, and lead to new therapeutic treatments. Infection by a pathogenic microorganism triggers a coordinated activation of both innate and adaptive immune responses. After initial contact between host and pathogen, host innate immune activation results in the production of multiple effector molecules, including cytokines and chemokines as well as antimicrobial proteins, to combat invading pathogens and parasites. In addition, the innate immune response quickly triggers an antimicrobial response that will initiate the development of a pathogen-specific, long-lasting adaptive immune response.

In this Special Issue, we aim to address the relevance of host-pathogen interactions for experimental and applied therapy. In particular, investigations into mechanisms and pathogenic strategies could provide new ideas to develop innovative tools that can be utilized to modulate microbial pathogenesis. We welcome the submission of research material focused on any of the different biological interaction points mentioned above, hoping that these will result in a better understanding of pathogen-host biological interactions and open new doors in scientific research.

Prof. Dr. Cinzia Giagulli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• host/pathogens interactions
• intracellular pathogens
• new therapeutic treatments